Litigation Details for Janssen Pharmaceutica, N.V. v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
✉ Email this page to a colleague
Janssen Pharmaceutica, N.V. v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-09-02 |
Court | District Court, N.D. West Virginia | Date Terminated | 2017-07-06 |
Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
Jury Demand | None | Referred To | |
Patents | 7,125,879; 8,101,629; 8,841,310 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Janssen Pharmaceutica, N.V. v. Mylan Pharmaceuticals, Inc.
Details for Janssen Pharmaceutica, N.V. v. Mylan Pharmaceuticals, Inc. (N.D.W. Va. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2015-09-02 | 1 | Mylan of U.S. Patent Nos. 8,841,310 B2 ("the '310 Patent"), 7,125,879 B2 ("the &…Exhibit A - Patent Information, # 2 Exhibit B - Patent Information, # 3 Exhibit C - Patent Information… '879 Patent") and 8,101,629 B2 ("the '629 Patent") (collectively, "the…the Patents-in-suit") arising under the patent laws of the United States, 35 U.S.C. ยงยง 1 et seq. …United States Patent and Trademark Office ("the PTO") issued the '310 Patent, entitled & | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |